Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity

American Journal of Translational Research

Volumn 5, Issue 1, 2013, Pages 21-35

  Rufaihah, Abdul Jalil ^a   Huang, Ngan F ^a   Kim, Jeanna ^a   Herold, Joerg ^a   Volz, Katharina S ^a   Park, Tea Soon ^b   Lee, Jerry C ^a   Zambidis, Elias T ^b   Reijo Pera, Renee ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Differentiation; Endothelial cells; Heterogeneity; Induced pluripotent stem cells

Indexed keywords

8 BROMO CYCLIC AMP; ANGIOPOIETIN 1; BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; MATRIGEL; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CONTROLLED STUDY; EMBRYOID BODY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN ISOLATION; PURIFICATION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 84872801167     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Leeper NJ, Hunter AL and Cooke JP. Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 2010; 122: 517-526.
2. Volz KS, Miljan E, Khoo A and Cooke JP. Development of pluripotent stem cells for vascular therapy. Vascular pharmacology 2012; 56: 288-296.
3. Rufaihah AJ, Huang NF, Jame S, Lee JC, Nguy- en HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS and Cooke JP. Endothelial cells derived from human iPSCS in- crease capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 2011; 31: e72-79.
4. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS and Chung HM. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007; 116: 2409-2419.
5. Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS and Cooke JP. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol 2010; 30: 984-991.
6. Li Z, Wilson KD, Smith B, Kraft DL, Jia F, Huang M, Xie X, Robbins RC, Gambhir SS, Weissman IL and Wu JC. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PloS one 2009; 4: e8443.
7. Nourse MB, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, Torok-Storb B, Rat- ner BD, Pabon L and Murry CE. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 2010; 30: 80-89.
8. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S and Nakao K. Pathway for differentiation of hu- man embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 2007; 27: 2127-2134.
9. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M and Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-96.
10. Yurugi-Kobayashi T, Itoh H, Schroeder T, Na-kano A, Narazaki G, Kita F, Yanagi K, Hiraoka- Kanie M, Inoue E, Ara T, Nagasawa T, Just U, Nakao K, Nishikawa S and Yamashita JK. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol 2006; 26: 1977-1984.
11. Coultas L, Chawengsaksophak K and Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005; 438: 937-945.
12. Hellstrom M, Phng LK and Gerhardt H. VEGF and Notch signaling: the yin and yang of angiogenic sprouting. Cell adhesion & migration 2007; 1: 133-136.
13. Lawson ND, Scheer N, Pham VN, Kim CH, Chit-nis AB, Campos-Ortega JA and Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001; 128: 3675-3683.
14. Lawson ND, Vogel AM and Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Developmental cell 2002; 3: 127-136.
15. Dyer LA and Patterson C. Development of the endothelium: an emphasis on heterogeneity. Semin Thromb Hemost 2010; 36: 227-235.
16. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007; 100: 174-190.
17. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007; 100: 158-173.
18. Goldman O, Feraud O, Boyer-Di Ponio J, Drian- court C, Clay D, Le Bousse-Kerdiles MC, Ben- naceur-Griscelli A and Uzan G. A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 2009; 27: 1750-1759.
19. Olsson AK, Dimberg A, Kreuger J and Claes-son-Welsh L. VEGF receptor signalling - in control of vascular function. Nature reviews. Molecular cell biology 2006; 7: 359-371.
20. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vanden- hoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439.
21. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW. Heterozygous embryonic le-thality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442.
22. DeLisser HM, Newman PJ and Albelda SM. Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol 1993; 184: 37-45.
23. DeLisser HM, Newman PJ and Albelda SM. Molecular and functional aspects of PECAM-1/ CD31. Immunol Today 1994; 15: 490-495.
24. Vittet D, Buchou T, Schweitzer A, Dejana E and Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A 1997; 94: 6273-6278.
25. Lanner F, Sohl M and Farnebo F. Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler Thromb Vasc Biol 2007; 27: 487-493.
26. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S and Yamashi-ta JK. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008; 118: 498-506.
27. Yamamizu K, Matsunaga T, Uosaki H, Fukushi-ma H, Katayama S, Hiraoka-Kanie M, Mitani K and Yamashita JK. Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors. The Journal of cell biology 2010; 189: 325-338.
28. Williams C, Kim SH, Ni TT, Mitchell L, Ro H, Penn JS, Baldwin SH, Solnica-Krezel L and Zhong TP. Hedgehog signaling induces arterial endothelial cell formation by repressing venous cell fate. Dev Biol 2010; 341: 196-204.
29. Krishnan V, Pereira FA, Qiu Y, Chen CH, Beachy PA, Tsai SY and Tsai MJ. Mediation of Sonic hedgehog-induced expression of COUP-TFII by a protein phosphatase. Science 1997; 278: 1947-1950.
30. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ and Tsai SY. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 2005; 435: 98-104.
31. Swift MR and Weinstein BM. Arterial-venous specifcation during development. Circ Res 2009; 104: 576-588.
32. Adams RH and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nature reviews. Molecular cell biology 2007; 8: 464-478.
33. Kiefer F and Adams RH. Lymphatic endothelial differentiation: start out with Sox--carry on with Prox. Genome biology 2008; 9: 243.
34. Maby-El Hajjami H and Petrova TV. Developmental and pathological lymphangiogenesis: from models to human disease. Histochem Cell Biol 2008; 130: 1063-1078.
35. Kume T. Specifcation of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 2010; 25: 637-646.
36. Tammela T, Saaristo A, Lohela M, Morisada T, Tornberg J, Norrmen C, Oike Y, Pajusola K, Thurston G, Suda T, Yla-Herttuala S and Alitalo K. Angiopoietin-1 promotes lymphatic sprout- ing and hyperplasia. Blood 2005; 105: 4642-4648.
37. Kono T, Kubo H, Shimazu C, Ueda Y, Takahashi M, Yanagi K, Fujita N, Tsuruo T, Wada H and Yamashita JK. Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler Thromb Vasc Biol 2006; 26: 2070-2076.
38. Liersch R, Nay F, Lu L and Detmar M. Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 2006; 107: 1214-1216.
39. Kreuger J, Nilsson I, Kerjaschki D, Petrova T, Alitalo K and Claesson-Welsh L. Early lymph vessel development from embryonic stem cells. Arterioscler Thromb Vasc Biol 2006; 26: 1073-1078.